News

Over 60 novel drug candidates are in late-stage clinical trials in China, and these will potentially compete directly with US ...
Ozempic a drug touted as a magical driving force for weight loss may be negatively affecting intimacy between couples ...
In India's rapidly growing anti-obesity drug landscape, Mounjaro (tirzepatide), launched by Eli Lilly in March 2025, is ...
Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...
The investigational dual GLP-1 and amylin receptor agonist Amycretin demonstrated significant weight loss—up to 24% with ...
Gabapentin, which is used to treat seizures, nerve pain and restless leg syndrome might be linked with increased risk of ...
Novo Nordisk's pipeline, especially the oral GLP-1 and Alzheimer’s trial, offers significant long-term upside. Click here to ...
Debilitating headaches are reducing their quality of life, but doctors say taking these steps can help.
A weight-loss doctor is warning patients not to rely on Wegovy as a cure for obesity, saying the newly available medication could be more harmful than helpful.
Glowbar Glowbar Medical Aesthetics is officially opening its doors in Bakersfield and it’s introducing luxury-level skincare ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...
Amanda Bynes shared she bought a grill instead of tooth gems due to having veneers, showcasing her sparkling new jewelry on ...